Kewaunee Scientific FY27 Q1 net earnings drop 44.85% to $1.71 million; net sales fall 6.7% to $66.32 million

• Kewaunee Scientific posted Q1 FY2027 net earnings attributable to shareholders of USD 1.71 million, down 44.85% year over year.
• Net sales fell 6.7% to USD 66.32 million; diluted EPS slid to USD 0.58 from USD 1.04.
• EBITDA dropped to USD 4.53 million from USD 6.32 million; pre-tax profit declined 34.7% to USD 2.56 million.
• Order backlog edged up to USD 169 million from USD 165.9 million since April 30; long-term debt excluding sale-leaseback fell to USD 13.8 million.
• CEO Thomas D. Hull III cited strong quoting activity, though award and release timelines remain extended amid geopolitical and economic uncertainty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609091615PR_NEWS_USPR_____CL44077) on September 09, 2026, and is solely responsible for the information contained therein.